Organon's Manufacturing Site Efficiencies
Expected to Improve Supply Chain Management and Speed Healthcare
Product Delivery
TEANACK, N.J., July 21,
2022 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today
announced it has signed a new multi-year agreement with Organon
(NYSE: OGN), a global women's health company, to help improve the
company's delivery of healthcare products and crucial medicinal
supply chain management.
Through the agreement, Cognizant will help scale Organon's
healthcare business by delivering full-stack industrial technology
support for the company's global pharmaceutical manufacturing sites
in the United Kingdom,
Netherlands, Belgium and Indonesia. This includes managing Organon's
manufacturing systems with SAP's S4/HANA enterprise application
suite. Additionally, by providing remote and onsite support
teams to increase real-time visibility of the manufacturing process
and ensure pharmaceutical development continuity, Cognizant seeks
to help Organon enhance supply chain oversight, increase medicinal
yields, reduce cycle times and get products to patients faster.
"Technology is an important pillar of differentiation for
Organon in fulfilling our mission of becoming the world's leading
women's health company," said Rachel
Stahler, Chief Information Officer at Organon. "By
partnering with Cognizant, we have teamed up with one of world's
top technology and professional services companies to advance our
digital ambitions and capabilities, along with speeding access to
important therapies for women everywhere."
"Our work with Organon to align its pharmaceutical development
with Industry 4.0 principles is crucial to supporting women's
health in an efficient, expedient and compliant approach," said
Surya Gummadi, Cognizant's SVP of Global Health Sciences and SVP,
Americas. "Partnerships like ours will help create new
opportunities for companies to transform their businesses and
deliver quality healthcare at scale."
Today, Cognizant works with each of the world's top 30
pharmaceutical companies. Its 2019 acquisition of Zenith
Technologies has enabled Cognizant to become one of the only global
organizations capable of providing end-to-end support for
pharmaceutical manufacturing systems. The combined Cognizant-Zenith
Technologies expertise delivers a range of Industry 4.0
capabilities, including machine sensor and controller
instrumentation, supervisory control, data acquisition and
automation. Most of Organon's manufacturing and supply program will
be managed and supported by leveraging Cognizant-Zenith
capabilities.
About Cognizant
Cognizant (Nasdaq: CTSH) engineers
modern businesses. We help our clients modernize technology,
reimagine processes and transform experiences so they can stay
ahead in our fast-changing world. Together, we're improving
everyday life. See how at www.cognizant.com or @cognizant.
For more
information, contact:
|
U.S.
Josh
Blumenthal
Joshua.Blumenthal@Cognizant.com
|
|
Europe /
APAC
Christina
Schneider
Christina.Schneider@Cognizant.com
|
|
India
Rashmi
Vasisht
Rashmi.Vasisht@Cognizant.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cognizant-teams-up-with-organon-to-speed-delivery-of-pharmaceutical-products-and-improve-womens-healthcare-301590433.html
SOURCE Cognizant